Last reviewed · How we verify
TEV-56286 Reference — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
TEV-56286 Reference (TEV-56286 Reference) — Teva Branded Pharmaceutical Products R&D LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TEV-56286 Reference TARGET | TEV-56286 Reference | Teva Branded Pharmaceutical Products R&D LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TEV-56286 Reference CI watch — RSS
- TEV-56286 Reference CI watch — Atom
- TEV-56286 Reference CI watch — JSON
- TEV-56286 Reference alone — RSS
Cite this brief
Drug Landscape (2026). TEV-56286 Reference — Competitive Intelligence Brief. https://druglandscape.com/ci/tev-56286-reference. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab